American Physiological Society

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

Retrieved on: 
Friday, April 5, 2024
Health, Medical Devices, Diabetes, Biometrics, Health Technology, Clinical Trials, Biotechnology, CGM, MARD, Venous blood, Know Labs, Machine, APS, Mayo Clinic, Blood, American Physiological Society, FDA

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster presentation at the American Physiological Society (APS) Summit in Long Beach, California on April 4-7, 2024.

Key Points: 
  • Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been selected for an abstract poster presentation at the American Physiological Society (APS) Summit in Long Beach, California on April 4-7, 2024.
  • At the previous APS Summit, Know Labs presented results from its peer-reviewed, proof-of-principle study conducted in collaboration with Mayo Clinic, which assessed the accuracy of its RF dielectric sensor in identifying different analytes in vitro, proving a 100% accuracy rate in these tests.
  • Since then, Know Labs has published several clinical studies demonstrating the stability, repeatability, and accuracy of its non-invasive continuous blood glucose monitor.
  • Most recently, Know Labs announced interim results from its first clinical research protocol involving people with diabetes, using venous blood as a comparative reference and a machine learning model trained on data collected in a lab setting, which resulted in an overall MARD of 11.1%.

Fauna Bio Announces Dr. Lara Do Amaral-Silva as Recipient of the CEPS FaunaBio Translational Research Award

Retrieved on: 
Monday, March 4, 2024
Oxygen, Wake Forest University, Breakfast, Animal, Physiology, Hypoxia, Myenteric plexus, Health, DSM-IV codes, APS, NMDA, Mammal, American Physiological Society, Genomics, Biology, Hibernation, Research, Human, Brain, Medical device

EMERYVILLE, Calif., March 4, 2024 /PRNewswire/ -- Fauna Bio, biotechnology company improving human health by leveraging animal genomics, announced today Dr. Lara Do Amaral-Silva, assistant professor of biology at Wake Forest University, as the recipient of the FaunaBio Translational Research Award through the American Physiological Society (APS).

Key Points: 
  • Her research focuses on the physiology of animals that can overcome metabolic challenges in the brain to gain overarching insights into brain diseases.
  • "While Fauna Bio is focused on data and discovery from mammals, we recognize there is important translational work being done in a broader range of species.
  • This important research highlights the resilience of brain function in animals under challenging conditions that would be fatal to humans," said Ashley Zehnder, Ph.D., CEO & Co-Founder, Fauna Bio.
  • The research also identified specific NMDA receptor subunits, GluN2B and GluN2C, as key players in mediating the NMDA receptor current.

Know Labs Furthers External Validation of Bio-RFID™ Technology with Study Published in Sensors Journal

Retrieved on: 
Thursday, May 18, 2023
Medical Devices, Health, Science, Other Science, Health Technology, Mayo Clinic, Education, APS, Cross-Cutting Programs Committee, Glucose, Know Labs, Research, American Physiological Society, Manuscript, Sensors (journal), FDA, Summit, NYSE, Medical device, Labs

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the publication of its first peer-reviewed study in Sensors Journal.

Key Points: 
  • Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the publication of its first peer-reviewed study in Sensors Journal.
  • Sensors is the leading international, peer-reviewed, open access journal on the science and technology of sensors.
  • “This is a big milestone for us,” said Ron Erickson, CEO and Chairman at Know Labs.
  • “We’re excited to publish this research in a scientific journal like Sensors to validate the work being done at Know Labs that is truly revolutionary,” said James “Andy” Anderson, M.D., Chief Medical Officer at Know Labs.

Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study

Retrieved on: 
Friday, April 21, 2023
Biotechnology, Publishing, Surgery, Health, FDA, Medical Devices, Communications, Health Technology, CGM, Sodium chloride, Mayo Clinic, Hertz, Education, APS, Peer review, Glucose, Know Labs, Research, American Physiological Society, Manuscript, Water, Radio, NYSE, Medical device, Medical imaging, Labs

Know Labs will present the results of the study at the American Physiological Society (APS) Summit, which is being held on April 20-23 in Long Beach, California.

Key Points: 
  • Know Labs will present the results of the study at the American Physiological Society (APS) Summit, which is being held on April 20-23 in Long Beach, California.
  • The study demonstrates the accuracy of Know Labs’ proprietary Bio-RFID™ sensor in quantifying different analytes in vitro, proving a 100% accuracy rate in these tests.
  • Know Labs’ technology platform, Bio-RFID, uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures, which can be converted into physiologically meaningful information and insights.
  • While the technology is proven to accurately measure several analytes inside and outside the body, the first application of this technology is aimed at non-invasive glucose monitoring.

American Counseling Association Names New Chief Communications and Marketing Officer

Retrieved on: 
Wednesday, January 25, 2023
American College, Marketing, Human, American Counseling Association, Senior counsel, Counselor, ACA, American Physiological Society, Trauma, Publishing, Executive, Social media, American College of Obstetricians and Gynecologists, African Publishers Network, Wisconsin Education Association Council, Mental health

ALEXANDRIA, Va., Jan. 25, 2023 /PRNewswire/ -- The American Counseling Association (ACA) has named Stacy Brooks Whatley as chief communications and marketing officer (CCMO) effective Feb. 13.

Key Points: 
  • ALEXANDRIA, Va., Jan. 25, 2023 /PRNewswire/ -- The American Counseling Association (ACA) has named Stacy Brooks Whatley as chief communications and marketing officer (CCMO) effective Feb. 13.
  • An award-winning communications, marketing and content strategist, Brooks Whatley has more than 20 years of experience in association communications.
  • "I look forward to working with Stacy in building critical communications and marketing strategies to advance ACA's mission and purpose," said CEO Shawn Boynes.
  • ACA's new CCMO most recently served as the director of marketing and communications for the American Physiological Society, overseeing strategic marketing, media relations, social media, website content strategy and overall communications outreach.

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

Retrieved on: 
Tuesday, March 1, 2022
Medical Devices, Surgery, Infectious Diseases, Cardiology, Other Education, Continuing, General Health, University, Health, Education, UPMC Altoona, Respiratory system, James, WHO, Journal, Journal of Applied Physiology, Hospital, FCCP, American Physiological Society, Medical director, Interstitial lung disease, World, Doctor of Philosophy, Emeritus, Vernon, Coronavirus Scientific Advisory Board (Turkey), University, South Tyrone Hospital, FDA, Physiology, Van Zandt, COVID-19, Jeffrey, Gas, UC San Diego School of Medicine, FACC, Gates Vascular Institute, COPD, Veterans Health Administration, Heart, Distinguishing, Lung, Professor, Technology, Physician, Centre County, Pennsylvania, Mayo Clinic School of Health Sciences, World Health Organization, Carbon, Pneumonia, Central, Pharmaceutical industry, Management, Medical device, Science, Medicine, MD

Dr. Sieck is a Vernon F. and Earline D. Endowed Professor and Distinguished Investigator at the Mayo Clinic School of Medicine and Science.

Key Points: 
  • Dr. Sieck is a Vernon F. and Earline D. Endowed Professor and Distinguished Investigator at the Mayo Clinic School of Medicine and Science.
  • MediPines technology is a highly innovative and broadly applicable approach that pushes the boundaries of respiratory science, said Dr. Sieck.
  • We are honored to welcome Dr. Sieck, Dr. Zlupko and Dr. Raney to our board of esteemed clinical thought leaders, said MediPines CEO Steve Lee.
  • MediPines existing Medical and Scientific Advisory Board of experts already includes John B.

ProSomnus® Sleep Technologies Adds John Remmers, MD, to Leadership Team

Retrieved on: 
Monday, September 27, 2021
OSA, Sleep, American Thoracic Society, Pharynx, Diagnosis, Pressure, CPAP, Physiology, Obstructive sleep apnea, Foothills Medical Centre, American College, Physician, American College of Chest Physicians, GLOBE, CEO, University, Journal of Applied Physiology, Sleep apnea, American Physiological Society, SAN, Splint (medicine), Neuroscience, Journal, Research, Internal medicine, Snoring, Pharmaceutical industry

SAN FRANCISCO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies, the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. John E. Remmers, MD, to their leadership team.

Key Points: 
  • SAN FRANCISCO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies, the leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. John E. Remmers, MD, to their leadership team.
  • "Millions of people around the world breathe better in their sleep thanks to the myriad contributions of Dr. John Remmers," noted Len Liptak, CEO.
  • ProSomnus is honored to work with John to further develop ProSomnus Oral Appliance Therapy devices as a leading treatment option."
  • I look forward with great anticipation to partnering with ProSomnus to improve the treatment of sleep apnea," stated John E. Remmers, MD.

Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology

Retrieved on: 
Tuesday, February 23, 2021
Medical specialties, Liver, Hepatology, Hepatitis, Non-alcoholic fatty liver disease, Fatty liver disease, American Physiological Society, American Association for the Study of Liver Diseases, American Journal of Physiology, Physiology, Melissa Palmer

The study titled "Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization" was published in the American Journal of Physiology - Gastrointestinal and Liver Physiology, a journal of the American Physiological Society.

Key Points: 
  • The study titled "Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization" was published in the American Journal of Physiology - Gastrointestinal and Liver Physiology, a journal of the American Physiological Society.
  • Dr. Chalasani is the leading author of the AASLD Practice Guidelines for the diagnosis and management of NAFLD/NASH disease.
  • There continues to be a concerted effort to accelerate the translation of innovative technologies to clinical studies and patient management.
  • The study is available at the American Journal of Physiology - Gastrointestinal and Liver Physiology website.

Molecular Stethoscope Announces Publication of its NAFLD/NASH Study in the American Journal of Physiology - Gastrointestinal and Liver Physiology

Retrieved on: 
Tuesday, February 23, 2021
Medical specialties, Liver, Hepatology, Hepatitis, Non-alcoholic fatty liver disease, Fatty liver disease, American Physiological Society, American Association for the Study of Liver Diseases, American Journal of Physiology, Physiology, Melissa Palmer

The study titled "Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization" was published in the American Journal of Physiology - Gastrointestinal and Liver Physiology, a journal of the American Physiological Society.

Key Points: 
  • The study titled "Non-invasive Stratification of Non-Alcoholic Fatty Liver Disease by Whole-transcriptome Cell-free mRNA Characterization" was published in the American Journal of Physiology - Gastrointestinal and Liver Physiology, a journal of the American Physiological Society.
  • Dr. Chalasani is the leading author of the AASLD Practice Guidelines for the diagnosis and management of NAFLD/NASH disease.
  • There continues to be a concerted effort to accelerate the translation of innovative technologies to clinical studies and patient management.
  • The study is available at the American Journal of Physiology - Gastrointestinal and Liver Physiology website.

SIUE's Gopalan Named 2020 Arthur C. Guyton Educator of the Year

Retrieved on: 
Wednesday, March 4, 2020
American Physiological Society, Pedagogy, Flipped classroom, Gopalan

EDWARDSVILLE, Ill., March 4, 2020 /PRNewswire-PRWeb/ --Hailed as an "exceptional mentor," "highly-accomplished and adaptable educator," and an "authority on implementing flipped classrooms methodology," Southern Illinois University Edwardsville's Chaya Gopalan, PhD, has been named the American Physiological Society's (APS) 2020 Arthur C. Guyton Educator of the Year.

Key Points: 
  • EDWARDSVILLE, Ill., March 4, 2020 /PRNewswire-PRWeb/ --Hailed as an "exceptional mentor," "highly-accomplished and adaptable educator," and an "authority on implementing flipped classrooms methodology," Southern Illinois University Edwardsville's Chaya Gopalan, PhD, has been named the American Physiological Society's (APS) 2020 Arthur C. Guyton Educator of the Year.
  • She is highly-regarded nationally for her commitment to implementing a range of teaching modalities to connect with diverse learners.
  • The distinguished Arthur C. Guyton Educator of the Year Award honors her for excellence in classroom teaching at the undergraduate, graduate and professional levels, and for her strong commitment to the improvement of physiology.
  • "I was totally shocked and simply could not believe that I was receiving this prestigious award," Gopalan said.